Dina Masi
2024
In 2024, Dina Masi earned a total compensation of $357.1K as Chief Financial Officer and Senior Vice President at Integrated Biopharma, a 8% increase compared to previous year.
Compensation breakdown
| Bonus | $6,300 |
|---|---|
| Option Awards | $60,060 |
| Salary | $280,000 |
| Other | $10,721 |
| Total | $357,081 |
Masi received $280K in salary, accounting for 78% of the total pay in 2024.
Masi also received $6.3K in bonus, $60.1K in option awards and $10.7K in other compensation.
Rankings
In 2024, Dina Masi's compensation ranked 154th out of 207 executives tracked by ExecPay. In other words, Masi earned more than 25.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 154 out of 207 | 26th |
Division Manufacturing | 61 out of 89 | 32nd |
Major group Chemicals And Allied Products | 25 out of 36 | 31st |
Industry group Drugs | 25 out of 33 | 24th |
Industry Pharmaceutical Preparations | 23 out of 30 | 23rd |
Source: SEC filing on October 28, 2024.
Masi's colleagues
We found two more compensation records of executives working with Dina Masi at Integrated Biopharma in 2024.
News
Integrated Biopharma CFO Dina Masi's 2024 pay rises 8% to $357K
October 28, 2024
Integrated Biopharma CFO Dina Masi's 2023 pay rises 10% to $330K
October 27, 2023
Integrated Biopharma CFO Dina Masi's 2022 pay rises 12% to $300K
October 27, 2022
Integrated Biopharma CFO Dina Masi's 2021 pay rises 6% to $268K
October 27, 2021
Integrated Biopharma CFO Dina Masi's 2019 pay rises 4% to $251K
October 28, 2019